Enhancing In Vitro Diagnostic Performance Through Hybrid Monitoring Strategies in Upcoming Xtalks Webinar
In the rapidly evolving landscape of in vitro diagnostics (IVDs), clinical performance studies are becoming increasingly intricate. As sponsors navigate this complexity, a hybrid monitoring approach is emerging as an essential strategy to enhance oversight and ensure compliance with regulatory standards. Xtalks is pleased to announce an insightful webinar designed to address these challenges, featuring distinguished experts from ARC Regulatory, including Dr. Ciara Devlin and Andrew Mercier.
Webinar Overview
Scheduled for October 1, 2026, at 10 AM EDT, this free webinar will delve into how hybrid monitoring can bolster the execution of clinical studies for IVDs. With the constantly shifting regulatory landscape, organizations face immense pressure to manage compliance, data quality, and operational efficiencies. The key to mastering these demands is an informed approach that integrates clinical, regulatory, and quality management expertise.
Understanding Hybrid Monitoring
The term 'hybrid monitoring' refers to a strategy that combines centralized oversight with structured on-site monitoring. This approach brings the best of both worlds, allowing for enhanced visibility across study activities and fostering proactive risk identification. By streamlining communication among various stakeholders, such as study sites and Clinical Research Associates (CRAs), the hybrid model facilitates quicker decision-making when challenges arise.
In this session, the audience will learn how ARC's innovative Sponsor Delegation Service serves as a cornerstone of their hybrid monitoring model. Developed by ARC's specialized regulatory team, this service empowers sponsors by providing seasoned clinical and regulatory knowledge while allowing them to maintain overarching responsibility for their studies. This collaboration results in effective governance and oversight, ensuring alignment with regulatory expectations and study timelines.
Key Benefits of the Hybrid Model
One of the principal advantages of this hybrid approach lies in its flexibility and scalability, tailoring solutions to meet the specific needs of diverse clinical studies. Organizations with limited internal resources or those seeking to optimize their study management processes can greatly benefit from the Sponsor Delegation framework. By alleviating operational complexities, sponsors can focus on innovation, paving the way for new diagnostic technologies to reach the market with confidence.
Moreover, with the integration of clinical operations, regulatory expertise, and quality management under one partner, studies can see improved consistency and minimized redundancy. The webinars promise to unpack these benefits in detail, providing valuable case studies and practical insights based on ARC's extensive experience supporting diagnostic studies.
Expert Insights
Dr. Ciara Devlin, who leads research operations at ARC, will share her knowledge on the practicalities of implementing a hybrid monitoring framework. Her insights will be complemented by Andrew Mercier, an Alliance Manager, who will discuss the strategic benefits of adapting these methodologies within the Diagnostic field.
Who Should Attend?
This webinar is targeted at professionals across the life sciences sector, including pharmaceutical and biotechnology companies, clinical research organizations, and medical device manufacturers. Whether you are involved in study design, compliance, or regulatory submissions, this event is an invaluable opportunity to gain insights into optimizing the execution of clinical studies.
Registration Information
To reserve your spot, visit the Xtalks website here and register for 'Transform IVD Performance with a Hybrid Monitoring Approach.' As the IVD space continues to innovate, staying informed is crucial for successfully navigating your organization through future challenges.
About Xtalks
Xtalks – The Life Science Community™ is a distinguished platform that offers professionals in pharma, biotech, medtech, healthcare, and research the insights and collaborative knowledge needed to drive the industry forward. Each year, Xtalks provides thousands of professionals with timely news, feature articles, webinars, podcasts, and curated job opportunities, empowering them to make informed decisions in a continually evolving field.
Join industry leaders and your peers in this enlightening webinar and discover how a hybrid monitoring strategy can transform your IVD studies!
Webinar Overview
Scheduled for October 1, 2026, at 10 AM EDT, this free webinar will delve into how hybrid monitoring can bolster the execution of clinical studies for IVDs. With the constantly shifting regulatory landscape, organizations face immense pressure to manage compliance, data quality, and operational efficiencies. The key to mastering these demands is an informed approach that integrates clinical, regulatory, and quality management expertise.
Understanding Hybrid Monitoring
The term 'hybrid monitoring' refers to a strategy that combines centralized oversight with structured on-site monitoring. This approach brings the best of both worlds, allowing for enhanced visibility across study activities and fostering proactive risk identification. By streamlining communication among various stakeholders, such as study sites and Clinical Research Associates (CRAs), the hybrid model facilitates quicker decision-making when challenges arise.
In this session, the audience will learn how ARC's innovative Sponsor Delegation Service serves as a cornerstone of their hybrid monitoring model. Developed by ARC's specialized regulatory team, this service empowers sponsors by providing seasoned clinical and regulatory knowledge while allowing them to maintain overarching responsibility for their studies. This collaboration results in effective governance and oversight, ensuring alignment with regulatory expectations and study timelines.
Key Benefits of the Hybrid Model
One of the principal advantages of this hybrid approach lies in its flexibility and scalability, tailoring solutions to meet the specific needs of diverse clinical studies. Organizations with limited internal resources or those seeking to optimize their study management processes can greatly benefit from the Sponsor Delegation framework. By alleviating operational complexities, sponsors can focus on innovation, paving the way for new diagnostic technologies to reach the market with confidence.
Moreover, with the integration of clinical operations, regulatory expertise, and quality management under one partner, studies can see improved consistency and minimized redundancy. The webinars promise to unpack these benefits in detail, providing valuable case studies and practical insights based on ARC's extensive experience supporting diagnostic studies.
Expert Insights
Dr. Ciara Devlin, who leads research operations at ARC, will share her knowledge on the practicalities of implementing a hybrid monitoring framework. Her insights will be complemented by Andrew Mercier, an Alliance Manager, who will discuss the strategic benefits of adapting these methodologies within the Diagnostic field.
Who Should Attend?
This webinar is targeted at professionals across the life sciences sector, including pharmaceutical and biotechnology companies, clinical research organizations, and medical device manufacturers. Whether you are involved in study design, compliance, or regulatory submissions, this event is an invaluable opportunity to gain insights into optimizing the execution of clinical studies.
Registration Information
To reserve your spot, visit the Xtalks website here and register for 'Transform IVD Performance with a Hybrid Monitoring Approach.' As the IVD space continues to innovate, staying informed is crucial for successfully navigating your organization through future challenges.
About Xtalks
Xtalks – The Life Science Community™ is a distinguished platform that offers professionals in pharma, biotech, medtech, healthcare, and research the insights and collaborative knowledge needed to drive the industry forward. Each year, Xtalks provides thousands of professionals with timely news, feature articles, webinars, podcasts, and curated job opportunities, empowering them to make informed decisions in a continually evolving field.
Join industry leaders and your peers in this enlightening webinar and discover how a hybrid monitoring strategy can transform your IVD studies!
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.